Ohsu Knight Cancer Institute

This study is testing whether the time of day a standard immunotherapy treatment is given affects how well it works for people with advanced solid tumors. Researchers want to see if a patient's internal body clock influences the treatment's effectiveness. About 160 participants w…

This study is testing a new, targeted radioactive drug called 177Lu-DOTATATE in patients with advanced breast cancer that has spread or returned. The drug is designed to seek out and attach to specific cancer cells, delivering radiation directly to the tumor to try to shrink it a…

This study is testing a two-part surgery for people with severe, long-term pancreas inflammation (chronic pancreatitis) and non-cancerous tumors. First, the entire pancreas is removed to stop the pain. Then, the patient's own insulin-producing cells are collected and transplanted…

This study is testing whether taking a short course of a hormone-modifying drug (ulipristal acetate) before a mammogram can temporarily reduce breast density. Dense breast tissue can hide cancer on a mammogram, making screening less effective. The goal is to see if this drug can …

This study is testing a new exercise program designed for people with primary brain tumors and the family members who care for them. The program involves patients and caregivers doing supervised, virtual strength training exercises together twice a week for 12 weeks. Researchers …